Understanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreNew Tests and Therapies Enable Personalized Cancer Treatment
Oncology is one of the most complex areas of medical care. Evernorth’s cancer consult service pairs subspecialists from leading cancer centers with community oncologists, improving access to the best ...
Read MoreWhat to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read MoreInnovation in hemophilia drug development and cost-efficiency tools
As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.
Read MoreHelping plans and patients get life-changing gene therapies
Gene therapies offer hope where none existed before, but health plans and employers need the right strategy to make these cutting-edge medications affordable and available.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreThe importance of utilization management within the medical benefit
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read MorePharmacy in Focus
See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.
Read MoreThe benefits of timely and actionable specialty reporting
A comprehensive suite of reporting tools—and the right specialty partner to interpret data—can be invaluable for plan sponsors.
Read MoreThe importance of a clinical-first approach to formulary development
The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.
Read More